More on Dexcom earnings

DexCom (DXCM) moves up on a solid Q2 earnings beat.

Product revenue grew 65% Y/Y. Total revenue, which included development grant and other revenue, grew 53% over the same period.

Product gross profit totaled $21.8M, compared to $10.6M in Q212.

Shares +12.9% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs